glp 1 reimbursement Medicaid Coverage of and Spending on GLP-1s GLP-1/GIP Tirzepatide Rx | FancyMeds

These new studies show small relative NAION risk with GLP-1s mostly in T2D patients (RR ~1.7-2.5), but absolute risks are very low (~0.02-0.08% over years) and attenuated after diabetes adjustment, suggesting confounding more than causation

Tattoo-machine microneedling enhanced delivery The rotary tattoo machine creates 1,890 micro-perforations per second at 2 mm depth, far more uniformly than manual dermarollers

Diabetes Medications and Risk of Parkinsons Disease: A Cohort Study of Patients With Diabetes

Mechanism of Action : Like Tesamorelin, CJC-1295 works by stimulating the release of growth hormone from the pituitary gland, subsequently increasing IGF-1 levels